Charles Matine - Director at Bionik Laboratories Corp.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
BNKL
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Charles Matine since 12/17/2023

Holdings reported by Charles Matine for Bionik Laboratories Corp.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.001 per share 207K $124K $0.60 Jun 9, 2023 Direct

Transactions reported by Charles Matine for Bionik Laboratories Corp.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.